Gilead's remdesivir gets U.S. FDA approval for use in hospitalized COVID-19 patients

  • 📰 YahooNews
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 59%

United States Headlines News

United States Latest News,United States Headlines

Gilead said it is currently meeting real-time demand for remdesivir, which is sold under the brand name Veklury, in the United States and anticipates meeting global demand by the end of October. Remdesivir, previously granted emergency use authorization by the FDA for COVID-19, was one of the drugs

- The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease.

Gilead said it is currently meeting real-time demand for remdesivir, which is sold under the brand name Veklury, in the United States and anticipates meeting global demand by the end of October. Remdesivir, previously granted emergency use authorization by the FDA for COVID-19, was one of the drugs used to treat U.S. President Donald Trump's coronavirus infection.

Remdesivir has become the standard of care for patients hospitalized with severe COVID-19 after a major study led by the National Institutes of Health showed that it reduced hospital stays by five days.The World Health Organization last week said its international trial of COVID-19 therapies found that remdesivir did not have a substantial effect on patients’ length of hospital stay or chances of survival. The study has not been reviewed by outside experts.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Didn’t I read a week ago it wasn’t effective?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 380. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA extends Covid-19 vaccine meeting to allow public inputThe FDA has added extra time to a daylong meeting Thursday of its vaccine advisers. The meeting will now include at least an hour and a half for public input, according to an agenda posted online. 2000: Vaccine skepticism is cool. 2010: Vaccine skepticism is anti-science. 2020: Vaccine skepticism is woke. Amazing to see the battle between big pharma creating the narrative of 'anti-vaxxers' being anti-science and Democrats claiming to be for science but anti-covid vaccine. Whatever they added are useless, America had a crazy selfish president, you just need to remove this Donald Trump, guaranteed America back to normal.
Source: CNN - 🏆 4. / 95 Read more »

U.S. FDA panel to discuss COVID-19 vaccine trials after emergency authorizationA panel of independent experts to the U.S. health regulator will decide on the nature of clinical trials that coronavirus vaccines should go through after receiving U.S. emergency use authorization. what sucker is going first? understand coronavirus vaccine and the three vaccine candidates now. Coronavirus Vaccines Candidates works only under these conditions. That doesn’t sound right
Source: Reuters - 🏆 2. / 97 Read more »

How Will The U.S. Distribute COVID-19 Antibody Drugs If They Get FDA Approval?COVID-19 antibody drugs appear to be helping people avoid hospitalization. Tens of thousands of people a day could be candidates to take the drugs, but the scarce supply has to be rationed.
Source: NPRHealth - 🏆 144. / 63 Read more »

FDA Approves Remdesivir For Covid-19 TreatmentThe drug was previously granted emergency use authorization, not full approval. It ain’t even gonna work How to end the COVID-19 pandemic StopCovid GreatLockdown SirEmmanuel12 ifb
Source: Forbes - 🏆 394. / 53 Read more »

Pfizer, J&J urge clarity from FDA on future of COVID-19 vaccine trials once a vaccine is availablePfizer Inc and Johnson & Johnson are seeking input from a U.S. Food and Drug Administration advisory committee on retaining and attracting volunteers for COVID-19 vaccine trials after a vaccine becomes available, if they know they might receive a placebo. Pourquoi que craignent ils death always exists! but for nothing, especially not for the innocent! invite to mercy! value for humanity! this is possible with your sensitivity. message to the universe the human right to live humanely behuman Sign human son human Breaknews the unscrupulous Once it's available. It won't be available 😳
Source: Reuters - 🏆 2. / 97 Read more »

States prepare for their own vaccine safety reviews amid worries about Trump’s influence on the FDASeveral states are setting up their own coronavirus vaccine reviews to counter public safety concerns as the Trump administration pushes the FDA to approve a shot on an aggressive timeline that they fear could be too rushed
Source: politico - 🏆 381. / 59 Read more »